Table 4.

Mutations present in cancer mucosa samples and frequencies of the same mutation appearing in adjacent nondysplastic mucosa of 11 patients with PSC-IBD.a

GeneMutationCancerAdjacent mucosaBoth cancer and mucosaNot present
MPLp.Arg102Pro0/110/111/1110/11
ATMp.Ala220Val1/110/110/1110/11
p.Asp1853Val0/110/111/1110/11
FLT3p.Ser102Phe0/110/111/1110/11
TP53p.Arg282Gln0/110/111/1110/11
p.Arg280Thr1/110/111/119/11
p.Arg273His1/110/110/1110/11
p.Val272Met1/110/110/1110/11
p.Glu2711/110/110/1110/11
p.Gly266Glu1/110/110/1110/11
p.Arg248Gln3/110/110/118/11
p.Arg175His1/110/110/1110/11
p.Trp1460/111/110/1110/11
ERBB2p.Ser310Phe1/110/110/1110/11
STK11p.Pro179Leu1/110/110/1110/11
ALKp.Gly756Ser1/110/110/1110/11
IDH1p.Asp220Gly0/110/111/1110/11
GNASp.Pro22Leu1/110/110/1110/11
p.Glu192Asp1/110/110/1110/11
MLH1p.Arg659Gln1/110/110/1110/11
CTNNB1p.Ile607Val0/110/111/1110/11
PIK3CAp.Asp725Asn1/110/110/1110/11
PDGFRAp.Thr200Ser0/110/111/1110/11
p.Arg293His0/110/111/1110/11
KDRp.Ser112Leu0/110/111/1110/11
FBXW7p.Arg465His1/110/111/119/11
p.Thr385Ile0/111/110/1110/11
p.Trp321Cys1/110/110/1110/11
EGFRp.Asn139Asp1/110/110/1110/11
CDKN2Ap.Arg128Gln1/110/110/1110/11
p.Arg581/110/110/1110/11
NOTCH1p.Arg1350Leu0/110/111/1110/11
p.Arg621His0/110/111/1110/11
GeneMutationCancerAdjacent mucosaBoth cancer and mucosaNot present
MPLp.Arg102Pro0/110/111/1110/11
ATMp.Ala220Val1/110/110/1110/11
p.Asp1853Val0/110/111/1110/11
FLT3p.Ser102Phe0/110/111/1110/11
TP53p.Arg282Gln0/110/111/1110/11
p.Arg280Thr1/110/111/119/11
p.Arg273His1/110/110/1110/11
p.Val272Met1/110/110/1110/11
p.Glu2711/110/110/1110/11
p.Gly266Glu1/110/110/1110/11
p.Arg248Gln3/110/110/118/11
p.Arg175His1/110/110/1110/11
p.Trp1460/111/110/1110/11
ERBB2p.Ser310Phe1/110/110/1110/11
STK11p.Pro179Leu1/110/110/1110/11
ALKp.Gly756Ser1/110/110/1110/11
IDH1p.Asp220Gly0/110/111/1110/11
GNASp.Pro22Leu1/110/110/1110/11
p.Glu192Asp1/110/110/1110/11
MLH1p.Arg659Gln1/110/110/1110/11
CTNNB1p.Ile607Val0/110/111/1110/11
PIK3CAp.Asp725Asn1/110/110/1110/11
PDGFRAp.Thr200Ser0/110/111/1110/11
p.Arg293His0/110/111/1110/11
KDRp.Ser112Leu0/110/111/1110/11
FBXW7p.Arg465His1/110/111/119/11
p.Thr385Ile0/111/110/1110/11
p.Trp321Cys1/110/110/1110/11
EGFRp.Asn139Asp1/110/110/1110/11
CDKN2Ap.Arg128Gln1/110/110/1110/11
p.Arg581/110/110/1110/11
NOTCH1p.Arg1350Leu0/110/111/1110/11
p.Arg621His0/110/111/1110/11

Abbreviation: PSC-IBD, concomitant primary sclerosing cholangitis and inflammatory bowel disease.

Table 4.

Mutations present in cancer mucosa samples and frequencies of the same mutation appearing in adjacent nondysplastic mucosa of 11 patients with PSC-IBD.a

GeneMutationCancerAdjacent mucosaBoth cancer and mucosaNot present
MPLp.Arg102Pro0/110/111/1110/11
ATMp.Ala220Val1/110/110/1110/11
p.Asp1853Val0/110/111/1110/11
FLT3p.Ser102Phe0/110/111/1110/11
TP53p.Arg282Gln0/110/111/1110/11
p.Arg280Thr1/110/111/119/11
p.Arg273His1/110/110/1110/11
p.Val272Met1/110/110/1110/11
p.Glu2711/110/110/1110/11
p.Gly266Glu1/110/110/1110/11
p.Arg248Gln3/110/110/118/11
p.Arg175His1/110/110/1110/11
p.Trp1460/111/110/1110/11
ERBB2p.Ser310Phe1/110/110/1110/11
STK11p.Pro179Leu1/110/110/1110/11
ALKp.Gly756Ser1/110/110/1110/11
IDH1p.Asp220Gly0/110/111/1110/11
GNASp.Pro22Leu1/110/110/1110/11
p.Glu192Asp1/110/110/1110/11
MLH1p.Arg659Gln1/110/110/1110/11
CTNNB1p.Ile607Val0/110/111/1110/11
PIK3CAp.Asp725Asn1/110/110/1110/11
PDGFRAp.Thr200Ser0/110/111/1110/11
p.Arg293His0/110/111/1110/11
KDRp.Ser112Leu0/110/111/1110/11
FBXW7p.Arg465His1/110/111/119/11
p.Thr385Ile0/111/110/1110/11
p.Trp321Cys1/110/110/1110/11
EGFRp.Asn139Asp1/110/110/1110/11
CDKN2Ap.Arg128Gln1/110/110/1110/11
p.Arg581/110/110/1110/11
NOTCH1p.Arg1350Leu0/110/111/1110/11
p.Arg621His0/110/111/1110/11
GeneMutationCancerAdjacent mucosaBoth cancer and mucosaNot present
MPLp.Arg102Pro0/110/111/1110/11
ATMp.Ala220Val1/110/110/1110/11
p.Asp1853Val0/110/111/1110/11
FLT3p.Ser102Phe0/110/111/1110/11
TP53p.Arg282Gln0/110/111/1110/11
p.Arg280Thr1/110/111/119/11
p.Arg273His1/110/110/1110/11
p.Val272Met1/110/110/1110/11
p.Glu2711/110/110/1110/11
p.Gly266Glu1/110/110/1110/11
p.Arg248Gln3/110/110/118/11
p.Arg175His1/110/110/1110/11
p.Trp1460/111/110/1110/11
ERBB2p.Ser310Phe1/110/110/1110/11
STK11p.Pro179Leu1/110/110/1110/11
ALKp.Gly756Ser1/110/110/1110/11
IDH1p.Asp220Gly0/110/111/1110/11
GNASp.Pro22Leu1/110/110/1110/11
p.Glu192Asp1/110/110/1110/11
MLH1p.Arg659Gln1/110/110/1110/11
CTNNB1p.Ile607Val0/110/111/1110/11
PIK3CAp.Asp725Asn1/110/110/1110/11
PDGFRAp.Thr200Ser0/110/111/1110/11
p.Arg293His0/110/111/1110/11
KDRp.Ser112Leu0/110/111/1110/11
FBXW7p.Arg465His1/110/111/119/11
p.Thr385Ile0/111/110/1110/11
p.Trp321Cys1/110/110/1110/11
EGFRp.Asn139Asp1/110/110/1110/11
CDKN2Ap.Arg128Gln1/110/110/1110/11
p.Arg581/110/110/1110/11
NOTCH1p.Arg1350Leu0/110/111/1110/11
p.Arg621His0/110/111/1110/11

Abbreviation: PSC-IBD, concomitant primary sclerosing cholangitis and inflammatory bowel disease.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close